Entity Common Stock, Shares Outstanding of Akari Therapeutics Plc from 31 Dec 2012 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Akari Therapeutics Plc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2012 to 13 Nov 2025.
  • Akari Therapeutics Plc Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 71,479,461,523.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Akari Therapeutics Plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 71,479,461,523 13 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 65,229,461,523 +41,322,562,000 +173% 13 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 57,752,981,523 +41,905,590,000 +264% 31 Mar 2025 10-K 15 Apr 2025 2024 FY
Q4 2024 49,517,115,523 15 Nov 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 23,906,899,523 09 Aug 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 15,847,391,523 29 Mar 2024 10-K 29 Mar 2024 2023 FY
Q4 2022 7,444,917,123 +2,685,185,200 +56% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q4 2021 4,759,731,923 +912,400,000 +24% 31 Dec 2021 20-F 16 May 2022 2021 FY
Q4 2020 3,847,331,923 +1,601,466,010 +71% 31 Dec 2020 20-F 21 Apr 2021 2020 FY
Q4 2019 2,245,865,913 +665,172,500 +42% 31 Dec 2019 20-F 31 Mar 2020 2019 FY
Q4 2018 1,580,693,413 +55,000,020 +3.6% 31 Dec 2018 20-F 23 Apr 2019 2018 FY
Q2 2018 1,525,693,393 +348,000,000 +30% 30 Jun 2018 6-K 27 Sep 2018 2018 Q2
Q4 2017 1,525,693,393 +348,000,010 +30% 31 Dec 2017 20-F 18 Jul 2018 2017 FY
Q2 2017 1,177,693,393 +1,177,693,393 30 Jun 2017 6-K 10 Aug 2017 2017 Q2
Q4 2016 1,177,693,383 0 0% 31 Dec 2016 20-F 31 Mar 2017 2016 FY
Q2 2016 0 -55,636,283 -100% 30 Jun 2016 6-K 14 Apr 2017 2016 Q2
Q1 2016 1,177,693,383 +1,122,057,100 +2017% 23 Mar 2016 10-K 23 Mar 2016 2015 FY
Q4 2015 1,177,693,383 +1,122,057,100 +2017% 16 Nov 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 55,636,283 12 Aug 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 55,636,283 12 May 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 55,636,283 +15,408,330 +38% 11 Feb 2015 10-K 11 Feb 2015 2014 FY
Q4 2013 40,227,953 +26,858,144 +201% 31 Dec 2013 20-F 24 Mar 2014 2013 FY
Q4 2012 13,369,809 31 Dec 2012 20-F/A 19 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.